TrialCancer immunology, immunotherapy : CII2011

Resistance to the proapoptotic effects of interferon-gamma on melanoma cells used in patient-specific dendritic cell immunotherapy is associated with improved overall survival.

A N Cornforth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.